From the perspective of macroeconomic policy, the general direction of the State Council is to encourage "Internet +" to promote the development of medical e-commerce; the health care reform of the Health and Family Commission promotes the separation of medicines and supports the outflow of prescription drugs. However, when it was implemented at the specific implementation level, the SFDA was pushed forward in two steps, out of the difficulty of drug safety supervision. The prescription drug retail and medical e-commerce appeared to be awkward.
Data show that pharmaceutical e-commerce is still the focus of Internet medical investment
In 2015, the domestic prescription drug market was about 1.2 trillion yuan, and the scale of the OTC market was as high as 200 billion yuan (source: Zhongkang CMH);
In 2013, US pharmaceutical e-commerce accounted for about 30% of total pharmaceutical sales, and prescription drugs accounted for about 50% of the total pharmaceutical e-commerce. Domestic pharmaceutical e-commerce (only for drugs) accounted for less than 1% of the overall pharmaceutical sales ratio, and domestic drug online sales are mainly OTC (Easy data shows that the 2015 OTC network sales of about 5 billion yuan), prescription drug online sales have been in an awkward position .
Policy changes are one of the themes of the development of pharmaceutical e-commerce, investment ups and downs
In 1999, the Interim Provisions on the Circulation Management of Prescription Drugs and Non-prescription Drugs banned the sale of prescription drugs and non-prescription drugs online, and the medical e-commerce business was aborted;
In 2005, the Interim Provisions on the Approval of Internet Drug Trading Services released the OTC online transaction. In 2006, the Food and Drug Administration issued the first medical B2C license. The investment in medical e-commerce began to take off, but it will not be counted as the first year of medical e-commerce until 2009-2010. The current top-ranking medical e-commerce companies such as Shaoyao.com, Qilekang and Kang Aiduo have been established. In 2012, China's medical e-commerce business ushered in a traffic dividend: the Tmall Medical Museum was established, and the traffic volume quadrupled that year;
In 2014, the "Internet Food and Drug Administration Supervision and Management Measures (Draft for Comment)" allowed the Internet platform to obtain prescription drugs to sell prescription drugs, and the third-party logistics distribution platform could be used for drug or medical device distribution. The liberalization of prescription drug online sales has led to a sharp rise in pharmaceutical e-commerce investment. The top five financing totals exceeded 100 million US dollars, respectively, 1 drug network nearly 2 billion yuan, Shanghai pharmaceutical cloud health 1.1 billion yuan, Qi Lekang 10 More than 100 million yuan, Ikondo billion yuan, Jianke network 100 million dollars.
Recent industry hotspots once again show policy volatility and alleviate the nerves of investors
On July 28, the State Food and Drug Administration issued the article “The End of the Online Retail Pilot Project for Internet Third-Party Platform Drugs†and notified the Hebei, Shanghai, and Guangdong Food and Drug Administrations to end the Tmall Medicine Museum, No. 1 The store and 800-party Internet drug retail pilot work announced the suspension of the pharmaceutical retail business of the third-party platform. It can be seen that for the online sales safety of prescription drugs, the FDA has not been able to come up with a more authoritative and systematic method to measure, so it has stopped first;
On July 25th, the National Development and Reform Commission issued the “Division Plan for the Key Work Departments of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industryâ€, which involved the relevant requirements of “the directional guidance for prohibiting medical institutions from restricting the outflow of prescriptions to be clear againâ€. This again shows the government's will to promote the separation of medicines and promote the outflow of prescription drugs.
Organic beetroot powder is made from organic beets that are dehydrated and then ground into a powder. Retaining all the protective nutrients of ripe beets, this powder is naturally rich in vitamins, minerals, and nitrate. The American Heart Association reports on a preliminary study, where a test group of people with high blood pressure consumed beetroot juice each day had a decrease in their blood pressure for the next 24 hours. With the highest sugar content of all the vegetables, organic beetroot powder is becoming increasingly popular as a sweetening substitute. Beet powder/juice powder is used to flavor carrot, celery, and other vegetable juices, while also being used to add color to a variety of foods and beverages. Commercially they`re also added to salad dressings, spaghetti sauces, and tomato products (juices and sauces).
Beetroot Powder,Organic Beet root Powder,Beetroot Juice Powder,Organic Beet root Juice Powder
Organicway (xi'an) Food Ingredients Inc. , https://www.organicwayince.com